Our data showed that the miRNA (miR-125a/miR-205) cluster (co-expression of miR-125a and miR-205) was more effective than either miRNA alone to down-regulate HER3 in HER2-over-expressing breast cancer cells [24]. The gene discussed is ERBB3; the disease is breast carcinoma.